Bob Baltera

Entrepreneur-in-Residence

Bob is an Entrepreneur-in-Residence on the Frazier Life Sciences team and a seasoned pharmaceutical executive with vast business and product management experience.

Bob joined Frazier in January 2016 and co-founded Hawkeye Therapeutics, a search company focused on in-licensing and developing high-quality assets from pharmaceutical companies.

Before joining Frazier, Bob was Chief Executive Officer of Amira Pharmaceuticals until its $475 million acquisition by Bristol-Myers Squibb in 2011. In this capacity, he was instrumental in focusing Amira's development efforts, strengthening its pipeline and forging key collaborations with partners such as GlaxoSmithKline. Previously, he held a number of senior management positions over 17 years at Amgen.

Bob serves on the board of directors for several companies and the San Diego Venture Group, and is a member of the board of trustees of the Keck Graduate Institute.

Bob earned his M.B.A. from the Anderson School at the University of California, Los Angeles; and a B.S. in microbiology and an M.S. in genetics from The Pennsylvania State University.

Location

San Diego

Education

University of California, Los Angeles (M.B.A.)
Pennsylvania State University (M.S., B.S.)

Year Joined

2016

Contact

Select Investments